Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy-Reference-Cited by-同舟云学术

Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy

Published:2018-02 Issue:2 Volume:36 Page:80.e17-80.e24
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Lebdai Souhil,Mathieu Romain,Leger Julie,Haillot Olivier,Vincendeau Sébastien,Rioux-Leclercq Nathalie,Fournier Georges,Perrouin-Verbe Marie-Aimée,Doucet Laurent,Azzouzi Abdel Rahmene,Rigaud Jérome,Renaudin Karine,Charles Thomas,Bruyere Franck,Fromont Gaelle

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference29 articles.

1. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013;Heidenreich;Eur Urol,2014

2. Influence of metabolic syndrome on prostate cancer stage, grade, and overall recurrence risk in men undergoing radical prostatectomy;Bhindi;Urology,2016

3. Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study;De Nunzio;BMC Cancer,2016

4. Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study;Sourbeer;BJU Int,2015

5. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort;Bhindi;Eur Urol,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of metabolic syndrome on testosterone levels in patients with metastatic prostate cancer: a real-world retrospective study;PeerJ;2024-08-01

2. Preoperative serum low-density lipoprotein cholesterol is an independent prognostic factor in patients with renal cell carcinoma after nephrectomy;Lipids in Health and Disease;2023-02-22

3. Metabolic Syndrome is Associated with Prostate Cancer Diagnosed on Biopsy but not the Gleason Score and the Number of Cancer-Positive Cores: A Prospective Controlled Study;Archivos Españoles de Urología;2023

4. The volume and thickness of preprostatic fat on MRIs are not associated with prostate cancer aggressiveness in men undergoing radical prostatectomy;Progrès en Urologie;2022-04

5. The tangled web of dyslipidemia and cancer: Is there any association?;Journal of Research in Medical Sciences;2022